FIELD: chemistry.
SUBSTANCE: aprotinin analogue with a TFFYGGSRGKRNNFKTEEY sequence is obtained, as well as a conjugate based thereon.
EFFECT: invention enables delivery of a compound or medicinal agent through the hematoencephalic barrier in mammals.
6 cl, 9 dwg, 6 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| APROTININ POLYPEPTIDES FOR TRANSPORT OF COMPOUND THROUGH BLOOD-BRAIN BARRIER | 2010 |
|
RU2611193C2 |
| INTENSIFICATION OF ACTION OF ANTICANCER AGENTS | 2006 |
|
RU2422143C2 |
| ETOPOSIDE AND DOXORUBICIN CONJUGATES FOR DRUG DELIVERY | 2009 |
|
RU2531591C2 |
| BLOOD BRAIN BARRIER SHUTTLE | 2013 |
|
RU2663120C2 |
| SHUTTLE FOR BLOOD-BRAIN BARRIER | 2013 |
|
RU2711552C2 |
| BIOLOGICALLY ACTIVE DERIVATIVES OF PEPTIDE VAPEEHPTLLTEAPLNPK | 2005 |
|
RU2377249C2 |
| SHUTTLE FOR BLOOD-BRAIN BARRIER | 2019 |
|
RU2754794C2 |
| COMPOSITION BASED ON HYDROPHOBIC AGENTS AND METHOD FOR PREPARING IT (VERSIONS) | 2009 |
|
RU2518240C2 |
| METHODS AND COMPOSITIONS FOR IMPROVED DELIVERY OF MACROMOLECULES | 2009 |
|
RU2522245C2 |
| BISPECIFIC ANTI-HAPTEN/ANTI-BLOOD BRAIN BARRIER RECEPTOR ANTIBODIES, COMPLEXES THEREOF AND THEIR USE AS BLOOD BRAIN BARRIER SHUTTLES | 2014 |
|
RU2693438C2 |
